N. Ford, A. Ball, R. Baggaley, M. Vitoria, D. Low-beer et al., The WHO public health approach to HIV treatment and care: looking back and looking ahead. The Lancet Infectious diseases, 2017.

, Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report, 2011.

, The Joint United Nations Programme on HIV and AIDS. UNAIDS Report on the Global AIDS Epidemic 2010.c2010, 2018.

M. Blot and L. Piroth, HIV infection in France in 2012: Reality, risks and challenges for a chronic multisystem disease

, Rev Mal Respir, vol.29, issue.6, pp.128-131, 2012.

M. Harris, B. Nosyk, R. Harrigan, V. D. Lima, C. Cohen et al., Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future. AIDS research and treatment, vol.2012, p.3502757, 2012.

B. S. Peters and K. Conway, Therapy for HIV: past, present, and future, Adv Dent Res, vol.23, issue.1, pp.23-30, 2011.

S. G. Deeks, S. R. Lewin, and D. V. Havlir, The end of AIDS: HIV infection as a chronic disease, Lancet, issue.13, pp.61809-61816, 2013.

, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendations for a public health approach, 2013.

M. G. Wilson, L. Chambers, J. Bacon, S. Rueda, M. Ragan et al., issues of comorbidity in HIV/AIDS: an overview of systematic reviews. Ontario HIV Treatment Network, 2010.

J. V. Baker, G. Peng, J. Rapkin, D. I. Abrams, M. J. Silverberg et al., CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection, Aids, vol.22, issue.7, pp.841-849, 2008.

S. G. Deeks and A. N. Phillips, HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity, BMJ, vol.338, 2009.

F. J. Palella, R. K. Baker, A. C. Moorman, J. S. Chmiel, K. C. Wood et al., Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study, Journal of acquired immune deficiency syndromes, vol.43, issue.1, pp.27-34, 2006.

C. C. Lamas, L. E. Coelho, B. J. Grinsztejn, and V. G. Veloso, Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study. Infection, p.28660356, 2017.

S. P. Eholie, F. N. Ello, P. A. Coffie, A. Hema, D. K. Minta et al., Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study, Trop Med Int Health, 2017.

W. Health, O. , and U. , Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa, Afr Health Sci, vol.1, issue.1, pp.30-31, 2001.

S. D. Lawn, A. D. Harries, X. Anglaret, L. Myer, and R. Wood, Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa, Aids, vol.22, issue.15, p.3816249, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00266588

S. P. Eholie, K. A. Tanon, M. Folquet-amorissani, I. Ouattara, Y. T. Aba et al.,

, Med Trop (Mars), vol.69, issue.5, pp.520-524, 2009.

, Programme national de prise en charge mé dicale des personnes vivant avec l'infection. Rapport annuel d'activité s 2011 du programme national de prise en charge médicale des personnes vivant avec l'infection du ministère de la santé et de la lutte contre le sida. c2011, 2012.

A. Beauliere, S. Toure, P. K. Alexandre, K. Kone, A. Pouhe et al., The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Cote d'Ivoire, PloS one, vol.5, issue.6, p.11213, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00521955

V. Angwenyi, C. Aantjes, M. Kajumi, J. De-man, B. Criel et al., Patients experiences of selfmanagement and strategies for dealing with chronic conditions in rural Malawi, PloS one, vol.13, issue.7, p.199977, 2018.

K. Seden, S. H. Khoo, D. Back, P. Byakika-kibwika, M. Lamorde et al., Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting, J Antimicrob Chemother, vol.68, issue.1, pp.1-3, 2013.

E. Ajuoga, S. S. Sansgiry, C. Ngo, and R. F. Yeh, Use/misuse of over-the-counter medications and associated adverse drug events among HIV-infected patients, Research in social & administrative pharmacy: RSAP, vol.4, issue.3, pp.292-301, 2008.

A. Kamekis, A. Bertsias, J. Moschandreas, E. Petelos, M. Papadakaki et al., Patients' intention to consume prescribed and non-prescribed medicines: A study based on the theory of planned behaviour in selected European countries, J Clin Pharm Ther, vol.43, issue.1, pp.26-35, 2018.

M. M. Aziz, I. Masood, M. Yousaf, H. Saleem, D. Ye et al., Pattern of medication selling and self-medication practices: A study from, PloS one, vol.13, issue.3, p.5863987, 2018.

M. Moshabela, H. Schneider, S. P. Silal, and S. M. Cleary, Factors associated with patterns of plural healthcare utilization among patients taking antiretroviral therapy in rural and urban South Africa: a cross-sectional study, BMC Health Serv Res, vol.12, p.3465179, 2012.

K. Peltzer, N. F. Preez, S. Ramlagan, and H. Fomundam, Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa, BMC Public Health, vol.8, p.2503977, 2008.

A. Ranzani, L. Oreni, M. Agro, L. Van-den-bogaart, L. Milazzo et al., Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older, Journal of acquired immune deficiency syndromes, vol.78, issue.2, pp.193-201, 2018.

K. K. Radtke, P. Bacchetti, K. Anastos, D. Merenstein, H. Crystal et al., Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study, Journal of acquired immune deficiency syndromes, vol.78, issue.2, p.5962283, 2018.

M. E. Ruiz, Risks of self-medication practices, Current drug safety, vol.5, issue.4, pp.315-338, 2010.

C. O. Schmidt and T. Kohlmann, When to use the odds ratio or the relative risk?, Int J Public Health, vol.53, issue.3, pp.165-172, 2008.

A. Diouf, T. J. Youbong, M. Maynart, M. Ndoye, F. L. Dieye et al., Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription

, Rev Epidemiol Sante Publique, vol.65, issue.4, pp.295-300, 2017.

N. Nombela, B. Kouadio, S. Toure, C. Seyler, Y. A. Flori et al., Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults: a 5-year cohort study in Cote d'Ivoire, Journal of acquired immune deficiency syndromes, vol.41, issue.2, pp.225-256, 2006.

L. D. Sander, K. Newell, P. Ssebbowa, D. Serwadda, T. C. Quinn et al., Hypertension, cardiovascular risk factors and antihypertensive medication utilisation among HIV-infected individuals in Rakai, Uganda, Trop Med Int Health, vol.20, issue.3, pp.391-397, 2015.

P. Central and P. , , p.4308448

K. Peltzer, N. Friend-du-preez, S. Ramlagan, H. Fomundam, and J. Anderson, Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in, Afr J Tradit Complement Altern Med, vol.7, issue.2, pp.125-162, 2009.

P. Central and P. ,

A. C. Justice and . Hiv, Curr HIV/AIDS Rep, vol.7, issue.2, p.20425560, 2010.

, Aging Consensus P. Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus, J Am Geriatr Soc, vol.60, issue.5, p.22568508, 2012.

, OMS. Global update on HIV treatment 2013: results, impact and opportunities, 2013.

, OMS. Lignes directrices combinées sur l'utilisation des antirétroviraux pour le traitement et la pré vention de l'infection à VIH: ré sumé des principales caracté ristiques et recommandations Juin, 2018.

, Straté gie de l'OMS pour la Médecine Traditionnelle pour, OMS, 2002.

S. K. Tayebati, G. Nittari, S. S. Mahdi, N. Ioannidis, F. Sibilio et al., Identification of World Health Organisation ship's medicine chest contents by Anatomical Therapeutic Chemical (ATC) classification codes, Int Marit Health, vol.68, issue.1, pp.39-45, 2017.

M. D. Furler, T. R. Einarson, S. Walmsley, M. Millson, and R. Bendayan, Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Patient Care STDS, vol.17, issue.4, pp.155-68, 2003.

M. Gimeno-gracia, M. J. Crusells-canales, J. Armesto-gomez, F. , and R. Mj, Prevalence of concomitant medications in older HIV+ patients and comparison with general population, HIV clinical trials, vol.16, issue.3, pp.117-141, 2015.

C. Holtzman, C. Armon, E. Tedaldi, J. S. Chmiel, K. Buchacz et al., Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population, J Gen Intern Med, p.23605401, 2013.

A. C. Justice, K. S. Gordon, M. Skanderson, E. J. Edelman, K. M. Akgun et al., Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals, Aids, vol.32, issue.6, p.5868488, 2018.

H. B. Krentz, I. Cosman, K. Lee, J. M. Ming, and M. J. Gill, Pill burden in HIV infection: 20 years of experience. Antivir Ther, vol.17, pp.833-873, 2012.

C. Marzolini, L. Elzi, S. Gibbons, R. Weber, C. Fux et al., Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study, Antivir Ther, vol.15, issue.3, pp.413-436, 2010.

A. Tseng, L. Szadkowski, S. Walmsley, I. Salit, and J. Raboud, Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients, Ann Pharmacother, vol.47, issue.11, pp.1429-1468, 2013.

S. Zhou, K. Martin, A. Corbett, S. Napravnik, J. Eron et al., Total daily pill burden in HIV-infected patients in the southern United States, AIDS Patient Care STDS, vol.28, issue.6, pp.311-318, 2014.

M. D. Furler, T. R. Einarson, S. Walmsley, M. Millson, and R. Bendayan, Polypharmacy in HIV: impact of data source and gender on reported drug utilization, AIDS Patient Care STDS, vol.18, issue.10, pp.568-86, 2004.

C. Marzolini, D. Back, R. Weber, H. Furrer, M. Cavassini et al., Ageing with HIV: medication use and risk for potential drug-drug interactions, J Antimicrob Chemother, vol.66, issue.9, pp.2107-2118, 2011.

T. T. Brown and G. Guaraldi, Multimorbidity and Burden of Disease, Interdiscip Top Gerontol Geriatr, vol.42, pp.59-73, 2017.

T. G. Harris, M. Rabkin, and W. M. El-sadr, Achieving the fourth 90: healthy aging for people living with HIV, Aids, vol.32, issue.12, pp.1563-1572, 2018.

J. L. Adams, M. L. Almond, E. J. Ringo, W. H. Shangali, and K. J. Sikkema, Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania, Int J Psychiatry Med, vol.43, issue.2, p.3731063, 2012.

B. T. Tadesse, E. A. Ashley, S. Ongarello, J. Havumaki, M. Wijegoonewardena et al., Antimicrobial resistance in Africa: a systematic review, BMC infectious diseases, vol.17, issue.1, p.5594539, 2017.